Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Novel TMT

WebsiteLinkedInTwittercbCrunchbase
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • United Kingdom
  • Africa
Investment stages
  • Seed
  • Series A
Industries
  • Fintech
  • Web3
  • Blockchain
  • Web3
  • Crypto
About
Novel TMT targets investments in Technology, media, and teleCommunication Tech sectors, emphasizing disruptive innovations and high growth potential.
Min check size
$500K
Max check size
$5M
Fund size
NPS

Investment Thesis

Novel TMT invests in Technology, media, and teleCommunication Tech sectors, with a focus on disruptive innovations and high growth potential opportunities.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

4D Molecular

Alentis Therapeutics

BioGeneration Capital Fund V

CARGO Therapeutics

Cymabay

Fire1

Hillstar Bio

Lexeo Therapeutics

ManaT Bio

Maplight Therapeutics

Octave Health

Pureos Bioventures Fund II

Ray Therapeutics

Terremoto Biosciences

Scion Fund I

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp